{"id":"https://openalex.org/W2116708359","doi":"https://doi.org/10.1177/1756287214555336","title":"An update on enzalutamide in the treatment of prostate cancer","display_name":"An update on enzalutamide in the treatment of prostate cancer","publication_year":2014,"publication_date":"2014-10-15","ids":{"openalex":"https://openalex.org/W2116708359","doi":"https://doi.org/10.1177/1756287214555336","mag":"2116708359","pmid":"https://pubmed.ncbi.nlm.nih.gov/25642291","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4294802"},"language":"en","primary_location":{"id":"doi:10.1177/1756287214555336","doi":"https://doi.org/10.1177/1756287214555336","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1756287214555336","pdf_url":null,"source":{"id":"https://openalex.org/S105165982","display_name":"Therapeutic Advances in Urology","issn_l":"1756-2872","issn":["1756-2872","1756-2880"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Urology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4294802","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016971686","display_name":"Axel S. Merseburger","orcid":"https://orcid.org/0000-0001-6467-3931","observed_orcids":["https://orcid.org/0000-0001-6467-3931"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Axel S. Merseburger","raw_affiliation_strings":["Department of Urology and Urologic Oncology, Hannover Medical School (MHH), Carl Neuberg Str. 1, 30625 Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology and Urologic Oncology, Hannover Medical School (MHH), Carl Neuberg Str. 1, 30625 Hannover, Germany","institution_ids":["https://openalex.org/I34809795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109651628","display_name":"Gabriel P. Haas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel P. Haas","raw_affiliation_strings":["Astellas Global Medical Affairs, Inc., Northbrook, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Global Medical Affairs, Inc., Northbrook, IL, USA","institution_ids":["https://openalex.org/I4210165171"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037080576","display_name":"Christoph A. von Klot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph-A. von Klot","raw_affiliation_strings":["Hannover Medical School (MHH), Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hannover Medical School (MHH), Hannover, Germany","institution_ids":["https://openalex.org/I34809795"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":null,"fwci":0.7418,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.5713491,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"7","issue":"1","first_page":"9","last_page":"21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":1.0},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8629999756813049},{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.8130000233650208},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/affirm-trial","display_name":"AFFIRM trial","score":0.781000018119812},{"id":"https://openalex.org/keywords/prevail-trial","display_name":"PREVAIL trial","score":1.0},{"id":"https://openalex.org/keywords/hormone-naive-prostate-cancer","display_name":"hormone-naive prostate cancer","score":0.8569999933242798},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.9079999923706055},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.8349999785423279},{"id":"https://openalex.org/keywords/skeletal-related-events","display_name":"skeletal-related events","score":0.9330000281333923},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7950000166893005},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.703000009059906},{"id":"https://openalex.org/keywords/seizures","display_name":"seizures","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.9898898005485535},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9166215658187866},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.854049026966095},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7557716965675354},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6703107357025146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6160681843757629},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6121851205825806},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5849404335021973},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.5335104465484619},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.4581772983074188},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39649027585983276},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.35987502336502075},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09386661648750305},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/1756287214555336","doi":"https://doi.org/10.1177/1756287214555336","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1756287214555336","pdf_url":null,"source":{"id":"https://openalex.org/S105165982","display_name":"Therapeutic Advances in Urology","issn_l":"1756-2872","issn":["1756-2872","1756-2880"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Urology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4294802","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4294802","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Urol","raw_type":"Text"},{"id":"pmid:25642291","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25642291","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in urology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:cf94f348ffdc43e28f31359957f4f42d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/cf94f348ffdc43e28f31359957f4f42d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutic Advances in Urology, Vol 7 (2015)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4294802","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4294802","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Urol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307769","display_name":"Astellas Pharma US","ror":"https://ror.org/05pw69n24"},{"id":"https://openalex.org/F4320324271","display_name":"Astellas Foundation for Research on Metabolic Disorders","ror":"https://ror.org/01cjash87"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W82248322","https://openalex.org/W1483018165","https://openalex.org/W1512914561","https://openalex.org/W1904433804","https://openalex.org/W1955591671","https://openalex.org/W1965002585","https://openalex.org/W1975818511","https://openalex.org/W1980057223","https://openalex.org/W1980244461","https://openalex.org/W1981989535","https://openalex.org/W1985734141","https://openalex.org/W1996389184","https://openalex.org/W1996739656","https://openalex.org/W2014751188","https://openalex.org/W2028481813","https://openalex.org/W2038291926","https://openalex.org/W2065142831","https://openalex.org/W2066112327","https://openalex.org/W2075529011","https://openalex.org/W2078699963","https://openalex.org/W2092515164","https://openalex.org/W2094835811","https://openalex.org/W2099018307","https://openalex.org/W2109783350","https://openalex.org/W2110534364","https://openalex.org/W2118564089","https://openalex.org/W2119504728","https://openalex.org/W2121023961","https://openalex.org/W2123230901","https://openalex.org/W2131952914","https://openalex.org/W2137126980","https://openalex.org/W2148643283","https://openalex.org/W2156408482","https://openalex.org/W2158397011","https://openalex.org/W2165782799","https://openalex.org/W2165840390","https://openalex.org/W2166918329","https://openalex.org/W2167547884","https://openalex.org/W2168063883","https://openalex.org/W2168108459","https://openalex.org/W2197176303","https://openalex.org/W2594852131"],"related_works":["https://openalex.org/W2166918329","https://openalex.org/W2092515164","https://openalex.org/W7074249628","https://openalex.org/W1505130590","https://openalex.org/W2595859672","https://openalex.org/W2148643283","https://openalex.org/W2053700053","https://openalex.org/W2138761833","https://openalex.org/W2310160918","https://openalex.org/W1799155051"],"abstract_inverted_index":{"Enzalutamide":[0,101,147,291],"is":[1,201,292],"an":[2],"oral":[3],"androgen":[4,13],"receptor":[5,14],"inhibitor":[6],"that":[7],"targets":[8],"multiple":[9],"steps":[10],"in":[11,26,57,65,92,116,129,151,157,164,184,194,215,233,260,265,269,280,288,295],"the":[12,18,104,226,261,266,281],"signaling":[15],"pathway.":[16],"In":[17],"randomized":[19],"phase":[20,84,161],"III":[21,85],"AFFIRM":[22,234],"study,":[23],"significant":[24,55,114],"improvements":[25,115],"survival":[27],"versus":[28,90],"placebo":[29,91,229,267],"were":[30,77,112,170,231,277,286],"observed":[31,232],"when":[32],"enzalutamide":[33,89,209,227,249,262,275],"was":[34,148,192,254],"used":[35],"as":[36,181],"a":[37,136,158,211,257],"treatment":[38,49,276],"for":[39,172],"patients":[40,93,140,154,165],"with":[41,50,94,141,145,166,237,248,251,274],"metastatic":[42],"castration-resistant":[43],"prostate":[44,167],"cancer":[45,168],"(mCRPC)":[46],"following":[47],"prior":[48],"docetaxel.":[51],"Additional":[52],"benefits":[53],"included":[54],"delay":[56],"time":[58],"to":[59],"first":[60,132],"skeletal-related":[61,133],"event,":[62],"and":[63,70,109,119,135,228,235,242],"improvement":[64],"several":[66,296],"measures":[67],"of":[68,73,106,126,131,139,196,222],"pain":[69,241],"health-related":[71],"quality":[72],"life.":[74],"Treatment":[75],"effects":[76],"consistent":[78],"across":[79],"all":[80,117,216],"prespecified":[81,120],"subgroups.":[82],"The":[83],"PREVAIL":[86],"study":[87,163],"evaluated":[88],"mCRPC":[95],"who":[96,169],"had":[97],"not":[98],"received":[99],"chemotherapy.":[100],"significantly":[102],"decreased":[103],"risk":[105,130],"radiographic":[107],"progression":[108],"death.":[110],"There":[111],"also":[113,149,278],"secondary":[118],"exploratory":[121],"endpoints,":[122],"including":[123],"delayed":[124],"initiation":[125],"chemotherapy,":[127],"reduction":[128],"event":[134],"high":[137],"percentage":[138],"objective":[142],"response":[143],"compared":[144],"placebo.":[146,252],"studied":[150,294],"hormone":[152],"na\u00efve":[153],"(as":[155],"monotherapy)":[156],"small,":[159],"open-label":[160],"II":[162],"eligible":[171],"androgen-deprivation":[173],"therapy.":[174],"A":[175],"prostate-specific":[176],"antigen":[177],"(PSA)":[178],"response,":[179],"defined":[180],"\u2a7e80%":[182],"decline":[183],"PSA":[185],"level":[186],"from":[187],"baseline":[188],"at":[189,256],"week":[190],"25,":[191],"achieved":[193],"92.5%":[195],"patients.":[197],"Long-term":[198],"follow":[199],"up":[200],"ongoing.":[202],"Despite":[203],"differences":[204],"between":[205,225],"these":[206],"three":[207,217],"trials,":[208],"displayed":[210],"favorable":[212],"safety":[213],"profile":[214],"patient":[218],"populations.":[219,300],"Similar":[220],"rates":[221],"adverse":[223],"events":[224],"groups":[230],"PREVAIL,":[236],"fatigue,":[238],"diarrhea,":[239],"back":[240],"hot":[243],"flashes":[244],"being":[245,293],"more":[246],"common":[247],"than":[250,264],"Hypertension":[253],"reported":[255,279,287],"higher":[258],"rate":[259],"group":[263,268],"PREVAIL.":[270],"Breast-related":[271],"disorders":[272],"associated":[273],"Monotherapy":[282],"trial.":[283,290],"Few":[284],"seizures":[285],"any":[289],"early":[297],"disease":[298],"state":[299]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}